{"id":46226,"title":"Amryt Pharma, Joe Wiley CEO","publisher":"Share Talk","author":"sharetalk","published":"2016-12-12T09:16:30+00:00","modified":"2019-01-27T20:45:35+00:00","canonical_url":"https://www.share-talk.com/amryt-pharma-joe-wiley-ceo/","markdown_url":"https://www.share-talk.com/amryt-pharma-joe-wiley-ceo.md","json_url":"https://www.share-talk.com/amryt-pharma-joe-wiley-ceo.json","category":"Podcasts","categories":["Podcasts"],"tags":["AMYT"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"Share Talk speak to #AMYT CEO Joe Wiley about their recent 'Transformational Licence Agreement' RNS of 5 Dec 2016. We also get some more background information about Amryt Pharma and their focus on best-in-class treatments for rare and orphan diseases."}